<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114802</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Estimated glucose disposal rate in patients under 18 years of age with type 1 diabetes mellitus and overweight or obesity</dc:title>
<dc:description xml:lang="en">Objective To assess the estimated glucose disposal rate (eGDR), insulin dose, and lipoprotein profile in children with type 1 diabetes mellitus (T1DM) and overweight or obesity as compared to children with T1DM and normal weight. Methods A total of 115 patients (aged 5-16 years) with T1DM on intensive insulin therapy were recruited. The following parameters were measured: weight, height, body mass index, waist and hip circumference, insulin dose, eGDR, glycosylated hemoglobin, blood pressure, and lipoprotein profile. Results were stratified by sex and age. Results No significant differences were found in eGDR between children with normal weight, overweight, and obesity. However, obese children older than 11 years had lower eGDR values (9.3 ± 1.3 vs 10.1 ± 0.8 mg kg-1min-1; p &lt; 0.01). Insulin dose was higher in overweight and obese children, especially in IU/m2/day (37.7 vs 36.1 vs 29.4 respectively; p &lt; 0.01). Obese children had higher low-density lipoprotein cholesterol levels than children with overweight and normal weight (106.5 vs 91.7 vs 91.5 mg/dL respectively; p &lt; 0.01). No correlation was found between waist circumference and the different markers of insulin resistance. Conclusions Values of eGDR values were lower in obese children with T1DM older than 11 years, and this may therefore be considered a marker of insulin resistance. Insulin dose was higher in diabetic patients with overweight or obesity, specially in IU/m2/day. Obese children with T1DM had a lipoprotein profile of cardiovascular risk. (AU)</dc:description>
<dc:creator>Ruiz Cano, Rafael</dc:creator>
<dc:creator>Palomo Atance, Enrique</dc:creator>
<dc:creator>León Martín, Alberto</dc:creator>
<dc:creator>Giralt Muiña, Juan</dc:creator>
<dc:creator>Ballester Herrera, M. José</dc:creator>
<dc:creator>Giralt Muiña, Patricio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo Comparar la tasa estimada de disposición de glucosa (TeDG), la dosis de insulina y el perfil lipoproteico en niños con diabetes mellitus tipo 1 (DM1) y sobrepeso-obesidad frente a niños con DM1 de peso normal. Métodos Se seleccionaron 115 pacientes (5-16 años) con DM1 e insulinoterapia intensiva. Se determinaron: peso, talla, índice de masa corporal, perímetro abdominal y de cadera, dosis de insulina, hemoglobina glucosilada, presión arterial y perfil lipoproteico. Los resultados se estratificaron por sexo y edad. Resultados No se encontraron diferencias en la TeDG entre los pacientes con peso normal, sobrepeso y obesidad. No obstante, los niños obesos mayores de 11 años mostraron valores inferiores en la TeDG (9,3 ± 1,3 vs 10,1 ± 0,8 mg kg-1min; p &lt; 0,01). Los niños con obesidad y sobrepeso precisaban dosis de insulina superiores a aquellos con peso normal, especialmente en UI/m2/día (37,7 vs 36,1 vs 29,4, respectivamente; p &lt; 0,007). Los niños con obesidad presentaban concentraciones de colesterol de las lipoproteínas de baja densidad superiores a aquellos con sobrepeso y peso normal (106,5 vs 91,7 vs 91,5 mg/dl, respectivamente; p &lt; 0,01). Asimismo, no se encontró correlación entre el perímetro abdominal y los distintos marcadores de resistencia a la insulina. Conclusiones La TeDG es inferior en niños obesos mayores de 11 años con DM1, por lo que podría considerarse como un marcador de resistencia a la insulina. Las necesidades de insulina son mayores en pacientes con sobrepeso-obesidad, especialmente cuando se cuantifican en UI/m2/día. Los pacientes obesos con DM1 presentan un perfil lipoproteico de riesgo cardiovascular (AU)</dc:description>
<dc:source>Endocrinol Nutr;60(7): 379-385, ago.-sept. 2013. tab</dc:source>
<dc:identifier>ibc-114802</dc:identifier>
<dc:title xml:lang="es">Tasa estimada de disposición de glucosa en pacientes menores de 18 años con diabetes mellitus tipo 1 y sobrepeso-obesidad</dc:title>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d1812^s22002</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d50524^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22231</dc:subject>
<dc:subject>^d36032^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d9951^s22080</dc:subject>
<dc:subject>^d37656</dc:subject>
<dc:subject>^d3944^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201309</dc:date>
</metadata>
</record>
</ibecs-document>
